You are here: Home Search Search Market Research Reports Chronic%20lymphocytic%20leukemia

Search

Did you mean
chronic%lymphocytic%leukemia
Your search for "Chronic%2520lymphocytic%2520leukemia" gave back 307884 results.

Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or PARP2 or EC 2.4.2.30) - Pipeline Review, H2 2018

Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
October 2018
Price: USD 3,500.00

Global CD20 Target Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

The global CD20 Target Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of...
Catalog: 
Pharmaceutical Manufacturing
GIR
Global
November 2023
Price: USD 3,480.00

Nicotinamide Phosphoribosyltransferase - Pipeline Review, H2 2020

Nicotinamide Phosphoribosyltransferase - Pipeline Review, H2 2020 Summary Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
October 2020
Price: USD 3,500.00

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H1 2018

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H1 2018 Summary Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
March 2018
Price: USD 3,500.00

Global Alemtuzumab Market Growth 2023-2029

Alemtuzumab is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL, it has been used as both a first line...
Catalog: 
Pharmaceutical Manufacturing
LPI
Global
February 2023
Price: USD 3,660.00

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) -...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
April 2021
Price: USD 2,000.00

Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
April 2021
Price: USD 2,000.00

Relapsed Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Relapsed Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Relapsed Chronic...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
May 2022
Price: USD 2,500.00

Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Refractory...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
May 2022
Price: USD 2,500.00

Global Alemtuzumab Market Research Report 2023

Alemtuzumab is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL, it has been used as both a first line...
Catalog: 
Healthcare
MRRPB5
Global
February 2023
Price: USD 2,900.00

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Drugs In Development, 2021

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Drugs In Development, 2021 Summary Histone Deacetylase 3 (SMAP45 or RPD3 2 or...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
August 2021
Price: USD 3,500.00

Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
March 2022
Price: USD 3,500.00

Nicotinamide Phosphoribosyltransferase - Pipeline Review, H2 2019

Nicotinamide Phosphoribosyltransferase - Pipeline Review, H2 2019 Summary Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
December 2019
Price: USD 3,500.00

COVID-19 Global & China Chronic Lymphocytic Leukemia (CLL) Treatment Market Research by Company, Type & Application 2015-2026

Summary The Chronic Lymphocytic Leukemia (CLL) Treatment market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog: 
Treatments
HYR
Global
March 2021
Price: USD 2,000.00

Neprilysin - Pipeline Review, H2 2019

Neprilysin - Pipeline Review, H2 2019 Summary Neprilysin (Neutral Endopeptidase 24.11 or Atriopeptidase or Common Acute Lymphocytic Leukemia Antigen...
Catalog: 
Drug Pipeline
Global Markets Direct
Global
December 2019
Price: USD 3,500.00

Contact Us for Custom Market Research Solutions

 

Custom Market Research Reports

Filter By Industry

Filter By Country

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected